Myelodysplastic Syndrome Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome With Excess Blasts-2 Intervention: Drug: BXCL701 Sponsor: Eric Stephen Winer, MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2023 Category: Research Source Type: clinical trials
A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Condition: Acute Myeloid Leukemia and Myelodysplastic Syndrome Intervention: Drug: QLF32101 Sponsor: Qilu Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2023 Category: Research Source Type: clinical trials
